Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle - Archive ouverte HAL Access content directly
Journal Articles Science Year : 2018

Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (2) , (2) , (1) , (1) , (3) , (2) , (1)
1
2
3

Abstract

Vinblastine, a potent anticancer drug, is produced by Catharanthus roseus (Madagascar periwinkle) in small quantities, and heterologous reconstitution of vinblastine biosynthesis could provide an additional source of this drug. However, the chemistry underlying vinblastine synthesis makes identification of the biosynthetic genes challenging. Here we identify the two missing enzymes necessary for vinblastine biosynthesis in this plant: an oxidase and a reductase that isomerize stemmadenine acetate into dihydroprecondylocarpine acetate, which is then deacetoxylated and cyclized to either catharanthine or tabersonine via two hydrolases characterized herein. The pathways show how plants create chemical diversity and also enable development of heterologous platforms for generation of stemmadenine-derived bioactive compounds.
Not file

Dates and versions

hal-02527609 , version 1 (01-04-2020)

Identifiers

Cite

Lorenzo Caputi, Jakob Franke, Scott Farrow, Khoa Chung, Richard Payne, et al.. Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle. Science, 2018, 360 (6394), pp.1235-1239. ⟨10.1126/science.aat4100⟩. ⟨hal-02527609⟩

Collections

UNIV-TOURS BBV
43 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More